Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |